<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">05151</article-id><article-id pub-id-type="doi">10.7554/eLife.05151</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group></article-categories><title-group><article-title>Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-20380"><name><surname>Kim</surname><given-names>Edward</given-names></name><aff><institution content-type="dept">Division of Molecular Medicine and Genetics, Department of Internal Medicine</institution>, <institution>University of Michigan Medical School</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20381"><name><surname>Wang</surname><given-names>Yuan</given-names></name><aff><institution content-type="dept">Gilbert Family Neurofibromatosis Institute, Center for Cancer and Immunology Research</institution>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20382"><name><surname>Kim</surname><given-names>Sun-Jung</given-names></name><aff><institution content-type="dept">Gilbert Family Neurofibromatosis Institute, Center for Cancer and Immunology Research</institution>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20383"><name><surname>Bornhorst</surname><given-names>Miriam</given-names></name><aff><institution content-type="dept">Gilbert Family Neurofibromatosis Institute, Center for Cancer and Immunology Research</institution>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20384"><name><surname>Jecrois</surname><given-names>Emmanuelle S</given-names></name><aff><institution content-type="dept">Gilbert Family Neurofibromatosis Institute, Center for Cancer and Immunology Research</institution>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20385"><name><surname>Anthony</surname><given-names>Todd E</given-names></name><aff><institution content-type="dept">Laboratory of Molecular Biology</institution>, <institution>Rockefeller University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20386"><name><surname>Wang</surname><given-names>Chenran</given-names></name><aff><institution content-type="dept">Department of Cancer Biology</institution>, <institution>University of Cincinnati College of Medicine</institution>, <addr-line><named-content content-type="city">Cincinnati</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20387"><name><surname>Li</surname><given-names>Yi E</given-names></name><aff><institution content-type="dept">Division of Molecular Medicine and Genetics, Department of Internal Medicine</institution>, <institution>University of Michigan Medical School</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20388"><name><surname>Guan</surname><given-names>Jun-Lin</given-names></name><aff><institution content-type="dept">Division of Molecular Medicine and Genetics, Department of Internal Medicine</institution>, <institution>University of Michigan Medical School</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20389"><name><surname>Murphy</surname><given-names>Geoffrey G</given-names></name><aff><institution content-type="dept">Molecular and Behavioral Neuroscience Institute</institution>, <institution>University of Michigan Medical School</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-20379"><name><surname>Zhu</surname><given-names>Yuan</given-names></name><aff><institution content-type="dept">Gilbert Family Neurofibromatosis Institute, Center for Cancer and Immunology Research</institution>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington</named-content></addr-line>, <country>United States</country><email>yzhu@childrensnational.org</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1156"><name><surname>Pan</surname><given-names>Duojia</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Johns Hopkins University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>12</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e05151</elocation-id><supplementary-material><ext-link xlink:href="elife-05151-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>13</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>22</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>Â© 2014, Kim et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Kim et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Individuals with neurofibromatosis type 1 (NF1) frequently exhibit cognitive and motor impairments and characteristics of autism. The cerebellum plays a critical role in motor control, cognition, and social interaction, suggesting that cerebellar defects likely contribute to NF1-associated neurodevelopmental disorders. Here we show that <italic>Nf1</italic> inactivation during early, but not late stages of cerebellar development, disrupts neuronal lamination, which is partially caused by overproduction of glia and subsequent disruption of the Bergmann glia (BG) scaffold. Specific <italic>Nf1</italic> inactivation in glutamatergic neuronal precursors causes premature differentiation of granule cell (GC) precursors and ectopic production of unipolar brush cells (UBCs), indirectly disrupting neuronal migration. Transient MEK inhibition during a neonatal window prevents cerebellar developmental defects and improves long-term motor performance of <italic>Nf1</italic>-deficient mice. This study reveals essential roles of Nf1 in GC/UBC migration by generating correct numbers of glia and controlling GC/UBC fate-specification/differentiation, identifying a therapeutic prevention strategy for multiple NF1-associcated developmental abnormalities.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice in this study were cared for according to the guidelines that were approved by the Animal Care and Use Committees of the University of Michigan at Ann Arbor, MI and the Children's National Medical Center in Washington, DC. The approved protocol number at the University of Michigan is PRO00004481. The project (ID# 30001543) was approved by the IACUC (Protocol#: 309-13-09) of the Children's National Medical Center at Washington.</p></fn></fn-group></back></article>